• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D

机构信息

GI Clinical Trials Unit, Royal Marsden Hospital, Sutton, UK.

出版信息

Ann Oncol. 2013 Oct;24 Suppl 6:vi57-63. doi: 10.1093/annonc/mdt344.

DOI:10.1093/annonc/mdt344
PMID:24078663
Abstract
摘要

相似文献

1
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胃癌：欧洲肿瘤内科学会（ESMO）、欧洲外科肿瘤学会（ESSO）和欧洲放射肿瘤学会（ESTRO）诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi57-63. doi: 10.1093/annonc/mdt344.
2
Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.胃癌：ESMO-ESSO-ESTRO诊断、治疗及随访临床实践指南
Eur J Surg Oncol. 2014 May;40(5):584-591. doi: 10.1016/j.ejso.2013.09.020.
3
Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胃癌：ESMO-ESSO-ESTRO诊断、治疗及随访临床实践指南
Radiother Oncol. 2014 Jan;110(1):189-94. doi: 10.1016/j.radonc.2013.09.015.
4
Saudi Oncology Society clinical management guideline series. Gastric cancer 2014.沙特肿瘤学会临床管理指南系列。2014年胃癌指南
Saudi Med J. 2014 Dec;35(12):1529-33.
5
Evaluation and management of gastric adenocarcinoma.胃腺癌的评估与管理
Nurs Clin North Am. 2001 Sep;36(3):543-52, xi.
6
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胃癌：欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2010 May;21 Suppl 5:v50-4. doi: 10.1093/annonc/mdq164.
7
[On the diagnosis and treatment of cancer of the stomach arising after surgery for ulcers].[关于溃疡手术后发生的胃癌的诊断与治疗]
Vopr Onkol. 1967;13(3):91-4.
8
Gastric cancer. Update on diagnosis, staging, and therapy.胃癌。诊断、分期及治疗的最新进展。
Postgrad Med. 1997 Oct;102(4):231-6, 241. doi: 10.3810/pgm.1997.10.343.
9
Survival Outcomes Among Patients With Gastric Adenocarcinoma Who Received Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery.接受细胞减灭术联合腹腔热灌注化疗的胃腺癌患者的生存结局。
JAMA Surg. 2019 Aug 1;154(8):780-782. doi: 10.1001/jamasurg.2019.1698.
10
Extremely Well-Differentiated Gastric Adenocarcinoma Arising in Pylorus with Minor Diffuse Adenocarcinoma Component.起源于幽门的高分化胃腺癌伴微小弥漫性腺癌成分
J Gastrointest Cancer. 2018 Mar;49(1):75-77. doi: 10.1007/s12029-016-9851-3.

引用本文的文献

1
Emerging role of circular RNAs in gastric cancer: From basic biology to clinical applications (Review).环状RNA在胃癌中的新兴作用：从基础生物学到临床应用（综述）
Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13617. Epub 2025 Jul 11.
2
Asymptomatic oesophageal stent fracture 21 months after insertion.支架植入21个月后出现无症状性食管支架断裂。
Radiol Case Rep. 2025 Mar 29;20(6):3031-3036. doi: 10.1016/j.radcr.2025.03.020. eCollection 2025 Jun.
3
Understanding the Role of Rho GTPase Activating Protein and Bone Marrow Kinase X: A Novel Target in Gastric Cancer Treatment.
了解Rho GTP酶激活蛋白和骨髓激酶X的作用：胃癌治疗的新靶点
Asian Pac J Cancer Prev. 2025 Mar 1;26(3):725-733. doi: 10.31557/APJCP.2025.26.3.725.
4
Immune checkpoint inhibitors plus paclitaxel-based chemotherapy oxaliplatin-based therapy as first-line treatment for patients with HER2-negative unresectable or metastatic gastric/gastroesophageal junction cancer: results of a multicenter retrospective study.免疫检查点抑制剂联合基于紫杉醇的化疗或基于奥沙利铂的疗法作为HER2阴性不可切除或转移性胃/胃食管交界癌患者的一线治疗：一项多中心回顾性研究的结果
Transl Cancer Res. 2025 Jan 31;14(1):327-339. doi: 10.21037/tcr-24-1089. Epub 2025 Jan 23.
5
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).《2024年韩国胃癌诊疗指南：基于证据的多学科方法（2022年指南更新）》
J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11.
6
Elucidating gastric cancer mechanisms and therapeutic potential of Adociaquinone A targeting EGFR: A genomic analysis and Computer Aided Drug Design (CADD) approach.解析 Adociaquinone A 靶向 EGFR 治疗胃癌的机制和潜力：基于基因组分析和计算机辅助药物设计（CADD）方法。
J Cell Mol Med. 2024 Oct;28(20):e70133. doi: 10.1111/jcmm.70133.
7
A case report on imaging findings of rare segmental necrotizing granulomatous neuritis of leprosy involving ulnar nerve.1例累及尺神经的麻风罕见节段性坏死性肉芽肿性神经炎影像学表现的病例报告
Qatar Med J. 2024 Jun 23;2024(3):31. doi: 10.5339/qmj.2024.31. eCollection 2024.
8
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective study.免疫检查点抑制剂联合基于紫杉醇的化疗与单纯化疗作为HER2阴性晚期胃癌一线治疗的多中心回顾性研究结果
J Gastrointest Oncol. 2024 Apr 30;15(2):585-596. doi: 10.21037/jgo-23-814. Epub 2024 Apr 28.
9
Comparison of Tepotinib, Paclitaxel, or Ramucirumab Efficacy According to the Copy Number or Phosphorylation Status of the Gene: Doublet Treatment versus Single Agent Treatment.根据 基因的拷贝数或磷酸化状态比较特泊替尼、紫杉醇或雷莫芦单抗的疗效：双联治疗与单药治疗。
Int J Mol Sci. 2024 Feb 1;25(3):1769. doi: 10.3390/ijms25031769.
10
Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on "Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. 2023, , 553".对格拉齐奥西等人的回复。pT3N0M0期胃癌切除患者辅助化疗的应用原理。评“陈等人。病理淋巴结阴性T3期胃癌的预后因素及辅助化疗的作用。2023年，，553”
J Pers Med. 2023 Jun 13;13(6):988. doi: 10.3390/jpm13060988.